NASDAQ:AMED
Amedisys Inc Stock News
$92.16
-0.300 (-0.324%)
At Close: Mar 28, 2024
Amedisys to acquire Evolution Health, terms not disclosed (NASDAQ:AMED)
01:25pm, Wednesday, 02'nd Feb 2022 Seeking Alpha
Amedisys (AMED) to acquire Evolution Health, LLC, a division of Envision Healthcare, doing business as Guardian Healthcare, Gem City, and Care Connection of Cincinnati
Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date
01:00pm, Monday, 31'st Jan 2022 GlobeNewswire Inc.
BATON ROUGE, La., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, will report results for
Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date
08:00am, Monday, 31'st Jan 2022
BATON ROUGE, La., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, will report results for th
Amedisys Honors 37 Employees with Annual Spirit of Excellence Award
09:15pm, Wednesday, 26'th Jan 2022 GlobeNewswire Inc.
BATON ROUGE, La., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, has recognized 37 employee
Amedisys appoints Chris Gerard as CEO effective April 15, 2022
01:31pm, Monday, 10'th Jan 2022 Seeking Alpha
Amedisys (AMED) announced that Chairman and CEO Paul Kusserow will retire as CEO on April 15th, 2022. Upon his retirement as CEO, Mr
United States At-Home Care Market Report 2021-2025 Featuring Kindred at Home, Amedisys, LHC Group, and Encompass Health Corp
10:23am, Thursday, 06'th Jan 2022 GlobeNewswire
Dublin, Jan. 06, 2022 (GLOBE NEWSWIRE) -- The "The US At-Home Care Market: Size, Trends & Forecast with Impact of COVID-19 (2021-2025)" report has been added to ResearchAndMarkets.com''s offering.
Amedisys to Present at the 40th Annual J.P. Morgan Healthcare Conference
01:00pm, Wednesday, 29'th Dec 2021 GlobeNewswire Inc.
BATON ROUGE, La., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Paul
New Strong Sell Stocks for December 29th
11:22am, Wednesday, 29'th Dec 2021 Zacks Investment Research
B, FPI, CGNX, AMED, and FSUGY have been added to the Zacks Rank #5 (Strong Sell) List on December 29, 2021.
Amedisys to Present at the 40th Annual J.P. Morgan Healthcare Conference
08:00am, Wednesday, 29'th Dec 2021
BATON ROUGE, La., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Paul B.
New Strong Sell Stocks for December 29th
07:40am, Wednesday, 29'th Dec 2021
B, FPI, CGNX, AMED, and FSUGY have been added to the Zacks Rank #5 (Strong Sell) List on December 29, 2021.
New Strong Sell Stocks for December 27th
03:39pm, Monday, 27'th Dec 2021 Zacks Investment Research
TXRH, VIOT, WBK, AMED and CGNX have been added to the Zacks Rank #5 (Strong Sell) List on December 27, 2021
New Strong Sell Stocks for December 27th
12:14pm, Monday, 27'th Dec 2021
TXRH, VIOT, WBK, AMED and CGNX have been added to the Zacks Rank #5 (Strong Sell) List on December 27, 2021
Bank of America Corp DE Decreases Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)
09:10am, Friday, 24'th Dec 2021 Dakota Financial News
Bank of America Corp DE reduced its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 13.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 345,377 shares of the health services providers stock after selling 54,172 shares during the quarter. Bank of []
Barclays Lowers Amedisys (NASDAQ:AMED) Price Target to $213.00
08:28am, Wednesday, 22'nd Dec 2021 ETF Daily News
Amedisys (NASDAQ:AMED) had its price objective decreased by Barclays from $236.00 to $213.00 in a research note released on Tuesday morning, Analyst Ratings Network reports. Barclays currently has an overweight rating on the health services providers stock. AMED has been the topic of several other reports. SVB Leerink raised their target price on Amedisys from [] The post Barclays Lowers Amedisys (NASDAQ:AMED) Price Target to $213.00 appeared first on ETF Daily News .
10 Bargain Stocks to Buy After Falling 30% in 2021
05:02pm, Monday, 20'th Dec 2021
If you're looking for bargain stocks to buy that are down 30% or more in 2021, that's not an easy task. Here are 10 that fit the bill.